Bei T - Search Results

1

Landscape of RB1 alterations in 22,432 Chinese solid tumor patients.

Xu G, Zheng J, Wang S, Wang Y, Li G, Wang N, She X, Duan W, Zhang H, Huang D, Bei T, Fu D, Yang J. Xu G, et al. Among authors: bei t. Ann Transl Med. 2022 Aug;10(16):885. doi: 10.21037/atm-22-3162. Ann Transl Med. 2022. PMID: 36110997 Free PMC article.

2

Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma.

Yang G, Su X, Yang H, Luo G, Gao C, Zheng Y, Xie W, Huang M, Bei T, Bai Y, Wang Z, Cai P, He H, Xiang J, Cai M, Zhang Y, Qu C, Fu J, Liu Q, Hu Y, Zhong J, Huang Y, Guo Q, Zhang X. Yang G, et al. Among authors: bei t. Ann Transl Med. 2021 Aug;9(15):1254. doi: 10.21037/atm-21-3352. Ann Transl Med. 2021. PMID: 34532391 Free PMC article.

3

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma.

He W, Leng X, Mao T, Luo X, Zhou L, Yan J, Peng L, Fang Q, Liu G, Wei X, Wang K, Wang C, Zhang S, Zhang X, Shen X, Huang D, Yi H, Bei T, She X, Xiao W, Han Y. He W, et al. Among authors: bei t. Oncologist. 2022 Feb 3;27(1):e18-e28. doi: 10.1093/oncolo/oyab011. Oncologist. 2022. PMID: 35305102 Free PMC article.

4

Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial.

Yang G, Su X, Huang Y, Luo G, Wang Z, Cai P, Zheng Y, Bei T, Huang M, Bai Y, He H, Xiang J, Cai M, Zhong J, Guo Q, Zhang X. Yang G, et al. Among authors: bei t. J Transl Med. 2023 Jun 24;21(1):411. doi: 10.1186/s12967-023-04273-6. J Transl Med. 2023. PMID: 37355621 Free PMC article. Clinical Trial.

5

Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients.

Yue D, Liu W, Chen C, Zhang T, Ma Y, Cui L, Gu Y, Bei T, Zhao X, Zhang B, Bai Y, Romero A, Xu-Welliver M, Wang C, Zhang Z, Zhang B. Yue D, et al. Among authors: bei t. Transl Lung Cancer Res. 2022 Feb;11(2):263-276. doi: 10.21037/tlcr-22-106. Transl Lung Cancer Res. 2022. PMID: 35280315 Free PMC article.

6

Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.

Gao G, Cui L, Zhou F, Jiang T, Wang W, Mao S, Wu F, Jiang F, Zhang B, Bei T, Xie W, Zhang C, Zhang H, Gao C, Zhao X, Bai Y, Zhou C, Ren S. Gao G, et al. Among authors: bei t. Int J Cancer. 2023 Jan 1;152(1):79-89. doi: 10.1002/ijc.34239. Epub 2022 Sep 5. Int J Cancer. 2023. PMID: 36062503 Free article.

7

Next-generation sequencing based detection of BRCA1 and BRCA2 large genomic rearrangements in Chinese cancer patients.

Hua D, Tian Q, Wang X, Bei T, Cui L, Zhang B, Bao C, Bai Y, Zhao X, Yuan P. Hua D, et al. Among authors: bei t. Front Oncol. 2022 Sep 6;12:898916. doi: 10.3389/fonc.2022.898916. eCollection 2022. Front Oncol. 2022. PMID: 36147908 Free PMC article.

8

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.

Song Z, Li Y, Chen S, Ying S, Xu S, Huang J, Wu D, Lv D, Bei T, Liu S, Huang X, Xie C, Wu X, Fu J, Hua F, Wang W, Xu C, Gao C, Cai S, Lu S, Zhang Y. Song Z, et al. Among authors: bei t. BMC Med. 2022 Feb 1;20(1):42. doi: 10.1186/s12916-022-02245-z. BMC Med. 2022. PMID: 35101045 Free PMC article. Clinical Trial.

9

China special issue on gastrointestinal tumors-NTRK fusion in a large real-world population and clinical utility of circulating tumor DNA genotyping to guide TRK inhibitor treatment.

Qi C, Zhou T, Bai Y, Chen H, Yuan J, Zhao F, Liu C, Ma M, Bei T, Chen S, Zhao X, Chen C, Shen L. Qi C, et al. Among authors: bei t. Int J Cancer. 2023 Dec 1;153(11):1916-1927. doi: 10.1002/ijc.34522. Epub 2023 Apr 23. Int J Cancer. 2023. PMID: 36946696

10

Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma.

Yan K, Zhang D, Chen Y, Lu W, Huang M, Cai J, Chen S, Bei T, Bai Y, Lv J, Fu Y, Zhang H. Yan K, et al. Among authors: bei t. Front Immunol. 2023 Mar 28;14:1116057. doi: 10.3389/fimmu.2023.1116057. eCollection 2023. Front Immunol. 2023. PMID: 37056769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page